Evidence map›Paper›PMID 42211868›Full record

ArticleJCEM case reports2026

Copeptin as a diagnostic tool in a patient with adipsia and hypernatremia.

Paula Condé Lamparelli Elias, Beatriz Ristow de Assunção, Antonio Carlos Dos Santos, Margaret de Castro, Lucila Leico Kagohara Elias, Ayrton Custódio Moreira

Abstract readCase Reports
In one paragraph

Article in JCEM case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Paula Condé Lamparelli EliasDepartment of Internal Medicine, Ribeirao Preto Medical School - University of Sao Paulo, Ribeirao Preto 14049-900, Brazil.ORCID https://orcid.org/0000-0002-2780-4813
Beatriz Ristow de AssunçãoDepartment of Internal Medicine, Ribeirao Preto Medical School - University of Sao Paulo, Ribeirao Preto 14049-900, Brazil.
Antonio Carlos Dos SantosDepartment of Medical Imaging, Hematology and Clinical Oncology, Ribeirao Preto Medical School - University of Sao Paulo, Ribeirao Preto 14049-900, Brazil.
Margaret de CastroDepartment of Internal Medicine, Ribeirao Preto Medical School - University of Sao Paulo, Ribeirao Preto 14049-900, Brazil.ORCID https://orcid.org/0000-0003-4932-4623
Lucila Leico Kagohara EliasDepartment of Physiology, Ribeirao Preto Medical School - University of Sao Paulo, Ribeirao Preto 14049-900, Brazil.
Ayrton Custódio MoreiraDepartment of Internal Medicine, Ribeirao Preto Medical School - University of Sao Paulo, Ribeirao Preto 14049-900, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Classic adipsic vasopressin deficiency features hypotonic polyuria and absent thirst despite hypernatremia. We report a 21-year-old patient with prior resected pilocytic astrocytoma who presented dehydration and hypernatremia of 158 mEq/L (158 mmol/L) (reference range, 135-145 mEq/L [SI: 135-145 mmol/L]). He denied thirst and had no polyuria or polydipsia. Plasma and urinary osmolalities were 317 mOsm/Kg (317 mmol/Kg) (reference range, 282-295 mOsm/Kg [282-295 mmol/Kg]) and 878 mOsm/Kg (878 mmol/Kg) (reference range, 200-1200 mOsm/Kg [200-1200 mmol/Kg]), respectively. After prescribed oral water intake, serum sodium normalized and urinary volume remained normal. To assess osmoregulation, plasma copeptin and thirst visual scale were assessed during 3% saline infusion. Despite increases in serum sodium, the patient reported no change in thirst, confirming adipsia. Copeptin value was 3.2 pmol/L at the end of the saline infusion (reference range, 3.7-43.3 pmol/L) and 4.1 pmol/L during hypovolemic hypernatremia, both low-normal values considering hypernatremia, suggesting impaired osmolality-driven vasopressin secretion. This case illustrates a partial defect in osmoregulatory vasopressin release with maintained renal response and highlights the diagnostic utility of osmotic-stimulated copeptin measurement for functional characterization of vasopressin dynamics in rare adipsic disorders.

Indexed as

adipsiacopeptinhypernatremiavasopressin deficiency

Identifiers

PMID42211868
PMCPMC13213079

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.